Welcome
Support Centre
05 July 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A Pilot Study of the Effect of a Hypertonic Saline/Dextran (HSD) Solution Compared to Mannitol in the Management of Raised Intracranial Pressure (ICP)
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN82121210
Date ISRCTN assigned30/09/2004
Local reference number(s)N0185139336
Public titleA Pilot Study of the Effect of a Hypertonic Saline/Dextran (HSD) Solution Compared to Mannitol in the Management of Raised Intracranial Pressure (ICP)
Scientific title
AcronymN/A
Disease/condition/study domainInjury, Occupational Diseases, Poisoning: Brain
Study hypothesisWhether hypertonic saline/dextran produces greater lowering of raised intracranial pressure and for a longer duration that an equiosmolar dose of mannitol.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaNot provided at time of registration
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/11/2001
Anticipated end date31/12/2004
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsPatients on the intensive care unit with brain injury and an intracranial monitor fitted will be eligible for entry into the study. Those with persistently elevated ICP despite usual management will be randomised to receive either mannitol 0.25 g/kg (the standard treatment at this point) or an equiosmolar dose of HSD. ICP will be recorded each minute using the standard ICU monitors. Patients will be eligible to receive up to three doses of the drug (Mannitol or HSD) if their clinical condition warrants it and there are no contra-indications. ICP will be monitored, for the purposes of the study, until eight hours since the last dose of HSD/mannitol.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingPlymouth Hospitals NHS Trust
Sponsor nameRecord Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameDr P D Macnaughton
Contact detailsIntensive Care Unit,
Level 04
Derriford Hospital
Derriford
Plymouth
United Kingdom
PL6 8DH
Contact telephone+44 (0)1752 792555
Contact fax+44 (0)1752 763287
Contact emailpeter.macnaughton@phnt.swest.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN82121210
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central